Greedy Insider · Filing
GRCE · Buy · Opaleye Management Inc.
Opaleye Management Inc. (10% owner) bought 21,390 shares of Grace Therapeutics, Inc. (GRCE) at $1.93, about $41K, on Oct 22, 2026, filed with the SEC on Oct 26, 2026.
Greediness Score 31 · Weak · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001493152-26-048591